| Literature DB >> 24773603 |
K M Ivester1, L L Couëtil, G E Moore, N J Zimmerman, R E Raskin.
Abstract
BACKGROUND: Inflammatory airway disease (IAD) in horses is a widespread, performance-limiting syndrome believed to develop in response to inhaled irritants in the barn environment.Entities:
Keywords: Bronchoalveolar lavage; Cytology; Endotoxin; Eosinophils; Particulates
Mesh:
Substances:
Year: 2014 PMID: 24773603 PMCID: PMC4895475 DOI: 10.1111/jvim.12333
Source DB: PubMed Journal: J Vet Intern Med ISSN: 0891-6640 Impact factor: 3.333
Figure 1Flow diagram of study subject enrollment and exclusion.
Prevalence and cytologic phenotype of inflammatory airway disease (IAD)
| Days in Training | Number of Horses | Number (%) [95% CI] Classified as IAD | Number (%) [95% CI] with Increased% Neutrophils | Number (%) [95% CI] with Increased% Mast Cells | Number (%) [95% CI] with Increased% Eosinophils | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 46 | NoHN: 30 | 35 (76) | NoHN: 22 (73) | 6 (13) | NoHN: 4 (13) | 31 (69) | NoHN: 20 (67) | 14 (31) | NoHN: 9 (30) |
| HN: 16 | HN: 13 (81) | HN: 2 (12.5) | HN: 11 (69) | HN: 5 (31) | ||||||
| 14 | 46 | NoHN: 31 | 34 (74) | NoHN: 25 (81) | 10 (22) | NoHN: 6 (19) | 29 (63) | NoHN: 21 (68) | 14 (31) | NoHN: 7 (23) |
| HN: 15 | HN: 9 (60) | HN: 4 (27) | HN: 8 (53) | HN: 7 (47) | ||||||
| 28 | 43 | NoHN: 29 | 33 (77) | NoHN: 21 (72) | 9 (21) | NoHN: 5 (17) | 22 (51) | NoHN: 15 (52) | 12 (28) | NoHN: 7 (24) |
| HN: 14 | HN: 12 (86) | HN: 4 (29) | HN: 7 (50) | HN: 5 (36) | ||||||
CI, confidence interval; NoHN, no hay net group; HN, hay net group.
IAD diagnosed by an increase in 1 or more inflammatory cell population.
Cytology data missing for 1 horse because of nondiagnostic cytologic preparation.
Figure 2Comparison of particulate exposures between groups. Dark gray = respirable particulates; light gray = inhalable particulates; Line = median; triangle = mean respirable particulates; diamond = mean inhalable particulates; box = interquartile range; whiskers = range; open circles = outliers; ***P < .001, **P = .0064.
Exposure of horses to particulates, endotoxin, and ammonia
| Respirable Particulates (mg/m3) | Inhalable Particulates (mg/m3) | Ammonia (ppm) | Respirable Endotoxin (EU/m3) | |
|---|---|---|---|---|
| Hay net | 0.28 (0.039–2.4) | 8.3 (2.8–19.4) | 2.87 (0.96–3.77) | 173.4 (32.4–997.6) |
| No hay net | 0.055 (ND–1.01) | 3.3 (0.50–9.8) | 3.5 (1.2–12.7) | 59.2 (6.9–730.9) |
Median (range). ND, not detectable; limit of detection = 0.028 mg/m3.
***P < .001, **P = .0064, *P = .018.
Figure 3Marginal generalized linear model of predicted % eosinophils in BALF over time. Dotted line = no hay net group; solid line = hay net group; bands = 95% confidence intervals of predicted marginal means. BALF, bronchoalveolar lavage fluid.
Spearman rank correlation between concentrations of particles, endotoxin, ammonia, in the breathing zone of horses
| Respirable Particulates | Inhalable Particulates | Respirable Endotoxin | |
|---|---|---|---|
| Respirable Particulates | 1 | ||
| Inhalable Particulates |
| 1 | |
| Respirable Endotoxin |
| 0.35 (0.072) | 1 |
| NH3 | −0.13 (0.35) | −0.12 (0.52) | −0.049 (0.67) |
Rs (P‐value). Statistically significant correlations are in bold.
Spearman rank correlation between measures of exposure to particles, endotoxin, ammonia, and fecal ova counts and proportion of eosinophils in bronchoalveolar lavage fluid (BALF)
| % Eosinophils in BALF | ||
|---|---|---|
| 14 Days in Training | 28 Days in Training | |
| Respirable Particulates [mg/m3] | 0.37 (0.012) | 0.38 (0.017) |
| Inhalable Particulates [mg/m3] | 0.32 (0.085) | 0.36 (0.088) |
| Respirable Endotoxin [EU/m3] | 0.34 (0.020) | 0.37 (0.018) |
| NH3 [ppm] | −0.29 (0.062) | −0.27 (0.088) |
| Number of days in barn before enrollment | −0.28 (0.11) | −0.32 (0.10) |
| Ova [eggs/g] | −0.041 (0.80) | 0.29 (0.79) |
Rs (P‐value).
Figure 4Fit plot of marginal generalized linear model at 28 days in training: % eosinophils in BALF versus respirable particulate exposure. Circles = observed; line = marginal generalized linear mixed model; band = 95% confidence interval of the predicted marginal mean. BALF, bronchoalveolar lavage fluid.